Authors: Fredenburgh, JC Stafford, AR Weitz, JI

Citation: Jc. Fredenburgh et al., Conformational changes in thrombin when complexed by serpins, J BIOL CHEM, 276(48), 2001, pp. 44828-44834

Authors: Liaw, PCY Becker, DL Stafford, AR Fredenburgh, JC Weitz, JI

Citation: Pcy. Liaw et al., Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor II in the presence of dermatan sulfate but not heparin, J BIOL CHEM, 276(24), 2001, pp. 20959-20965

Authors: Anderson, JAM Fredenburgh, JC Stafford, AR Guo, YS Hirsh, J Ghazarossian, V Weitz, JI

Citation: Jam. Anderson et al., Hypersulfated low molecular weight heparin with reduced affinity for antithrombin acts as an anticoagulant by inhibiting intrinsic tenase and prothrombinase, J BIOL CHEM, 276(13), 2001, pp. 9755-9761

Authors: Liaw, PCY Austin, RC Fredenburgh, JC Stafford, AR Weitz, JI

Citation: Pcy. Liaw et al., Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombininactivation by heparin cofactor II, J BIOL CHEM, 274(39), 1999, pp. 27597-27604

Authors: Becker, DL Fredenburgh, JC Stafford, AR Weitz, JI

Citation: Dl. Becker et al., Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II, J BIOL CHEM, 274(10), 1999, pp. 6226-6233

Authors: Weitz, JI Young, E Johnston, M Stafford, AR Fredenburgh, JC Hirsh, J

Citation: Ji. Weitz et al., Vasoflux, a new anticoagulant with a novel mechanism of action, CIRCULATION, 99(5), 1999, pp. 682-689